Security key
22407B108
Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA)
CUSIP: 22407B108
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 1,101,849
- Total 13F value
- $4,368,596
- Share change
- +10,432
- SEC-reported price per share
- $3.97
- Number of holders
- 7
- Value change
- +$41,079
- Number of buys
- 5
- Shares outstanding
- 23,172,091
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
7
Top holders
7
COYA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Coya Therapeutics, Inc. SEC filings
Coya Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22407B108
Recent filing periods:
Ownership snapshot
Top reported holders of COYA - Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AIGH Capital Management LLC
Disclosed value leader
Bertex LLC
Comparable rows
4/6
Latest evidence
27 Feb 2023
13F
3/4/5
Lead comparable stake: 2.4%
2 rows are not safely comparable across share classes.
Quick read
AIGH Capital Management LLC leads the comparable SEC ownership view at 2.4%.
4 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AIGH Capital Management LLC's linked filing trail.
Comparable ownership
Top 4
AIGH Capital Management LLC
2.4%
GREENLIGHT CAPITAL INC
1.7%
Worth Venture Partners, LLC
0.59%
UBS Group AG
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
Company
|
2.4%
|
$2,653,336
560,000 shares
|
— | 31 Dec 2022 |
| GREENLIGHT CAPITAL INC |
13F
Company
|
1.7%
|
$1,859,439
392,444 shares
|
— | 31 Dec 2022 |
| Worth Venture Partners, LLC |
13F
Company
|
0.59%
|
$637,820
137,758 shares
|
— | 31 Dec 2022 |
| UBS Group AG |
13F
Company
|
0.01%
|
$5,759
1,215 shares
|
— | 31 Dec 2022 |
| Bertex LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$6,892,674
939,338 shares
|
— | 28 Dec 2022 |
| Adrian Hepner |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
—
115,000 shares
|
— | 27 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
1,101,849
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q3 2025 Across Filers
Q3 2025 holders
35
Q1 2023 holders
7
Holder diff
-28
| Investor | Q3 2025 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend